Manming N. Cao

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial.

Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 08, 2025

RC48-ADC monotherapy or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma with HER2 low and null expression: a multicenter, real-world, retrospective study.

RC48-ADC monotherapy or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma with HER2 low and null expression: a multicenter, real-world, retrospective study.

Journal: BMC cancer

Published: February 05, 2025

Correlation between IL3 signaling pathway-related genes and immune checkpoint inhibitor efficacy in patients with renal cell carcinoma.

Correlation between IL3 signaling pathway-related genes and immune checkpoint inhibitor efficacy in patients with renal cell carcinoma.

Journal: Cancer biomarkers : section A of Disease markers

Published: December 03, 2023

Corrigendum to "Long-term Follow-up of Detaenial Sigmoid Neobladder Reconstruction for Paediatric Patients with Bladder and Prostate Rhabdomyosarcoma: Technique and Results from a Single High-volume Centre" [Eur Urol 2022;82(5):543-550].

Corrigendum to "Long-term Follow-up of Detaenial Sigmoid Neobladder Reconstruction for Paediatric Patients with Bladder and Prostate Rhabdomyosarcoma: Technique and Results from a Single High-volume Centre" [Eur Urol 2022;82(5):543-550].

Journal: European urology

Published: February 26, 2023

HER2-targeting antibody-drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study.

HER2-targeting antibody-drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study.

Journal: Cancer immunology, immunotherapy : CII

Published: November 18, 2022

Long-term Follow-up of Detaenial Sigmoid Neobladder Reconstruction for Paediatric Patients with Bladder and Prostate Rhabdomyosarcoma: Technique and Results from a Single High-volume Centre.

Long-term Follow-up of Detaenial Sigmoid Neobladder Reconstruction for Paediatric Patients with Bladder and Prostate Rhabdomyosarcoma: Technique and Results from a Single High-volume Centre.

Journal: European urology

Published: May 13, 2022

UBE3A deletion enhances the efficiency of immunotherapy in non-small-cell lung cancer.

UBE3A deletion enhances the efficiency of immunotherapy in non-small-cell lung cancer.

Journal: Bioengineered

Published: May 09, 2022

Hypoxic Characteristic Genes Predict Response to Immunotherapy for Urothelial Carcinoma.

Hypoxic Characteristic Genes Predict Response to Immunotherapy for Urothelial Carcinoma.

Journal: Frontiers in cell and developmental biology

Published: August 22, 2021

Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma.

Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma.

Journal: Frontiers in pharmacology

Published: June 10, 2021

Nestin is essential for cellular redox homeostasis and gastric cancer metastasis through the mediation of the Keap1-Nrf2 axis.

Nestin is essential for cellular redox homeostasis and gastric cancer metastasis through the mediation of the Keap1-Nrf2 axis.

Journal: Cancer cell international

Published: May 24, 2021

Influence of Different Age Cutoff Points on the Prediction of Prognosis of Cancer Patients Receiving ICIs and Potential Mechanistic Exploration.

Influence of Different Age Cutoff Points on the Prediction of Prognosis of Cancer Patients Receiving ICIs and Potential Mechanistic Exploration.

Journal: Frontiers in oncology

Published: March 05, 2021

High mutations in fatty acid metabolism contribute to a better prognosis of small-cell lung cancer patients treated with chemotherapy.

High mutations in fatty acid metabolism contribute to a better prognosis of small-cell lung cancer patients treated with chemotherapy.

Journal: Cancer medicine

Published: February 19, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026